Influenza and Other Respiratory Viruses
Scope & Guideline
Shaping the future of infectious disease research.
Introduction
Aims and Scopes
- Epidemiology of Respiratory Viruses:
Research focused on the patterns, causes, and effects of respiratory viruses, including seasonal trends and outbreak dynamics across various populations and geographical locations. - Vaccine Effectiveness and Immunology:
Investigating the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2, as well as the immunological responses elicited by these vaccines in different demographic groups. - Clinical Outcomes and Disease Burden:
Studies assessing the clinical implications of infections caused by respiratory viruses, including hospitalization rates, morbidity, mortality, and overall health impact on affected populations. - Diagnostic Methods and Innovations:
Exploration of novel diagnostic techniques and technologies for the identification and management of respiratory infections, enhancing timely clinical decisions. - Antiviral Treatments and Therapeutic Strategies:
Research into the efficacy and safety of antiviral medications and other therapeutic interventions aimed at treating infections caused by respiratory viruses. - Surveillance and Public Health:
Efforts to enhance surveillance systems for respiratory viruses, providing insights into transmission dynamics and informing public health responses.
Trending and Emerging
- COVID-19 Vaccine Efficacy and Safety:
A significant increase in studies evaluating the effectiveness and safety of various COVID-19 vaccines, reflecting ongoing global vaccination efforts and the need for continuous assessment of vaccine performance. - Long COVID and Post-Viral Syndromes:
Emerging research focusing on the long-term effects of COVID-19, including 'Long COVID' symptoms, is gaining prominence as the medical community seeks to understand and address these complex health issues. - Impact of Non-Pharmaceutical Interventions:
Studies examining the effects of non-pharmaceutical interventions (NPIs) on respiratory virus transmission patterns, particularly during the COVID-19 pandemic, are increasingly relevant for future public health strategies. - Variants of Concern and Their Epidemiology:
Research centered on the epidemiology and clinical implications of SARS-CoV-2 variants, particularly Omicron and its sublineages, has surged as understanding these variants is critical for managing future outbreaks. - Artificial Intelligence in Diagnostics:
The integration of artificial intelligence and machine learning in the diagnosis and management of respiratory viruses, enhancing speed and accuracy in clinical settings, is an emerging trend.
Declining or Waning
- Non-Influenza Respiratory Viruses:
Research specifically targeting non-influenza respiratory viruses, while still relevant, appears to be receiving comparatively less attention as the focus has shifted towards COVID-19 and its variants. - Historical Analysis of Past Pandemics:
Studies examining the historical impact of past influenza pandemics are less frequently published, likely overshadowed by contemporary issues related to COVID-19. - Animal Models for Viral Research:
While still important, the use of animal models in studying respiratory viruses may be declining as more emphasis is placed on human epidemiological studies and clinical trials. - Influenza D Virus Research:
Research on influenza D virus has waned, possibly due to its relatively low impact on human health compared to other respiratory viruses like influenza A/B and SARS-CoV-2. - Longitudinal Studies of Seasonal Variability:
Long-term studies tracking seasonal variability of respiratory viruses have decreased, as immediate responses to emerging threats like COVID-19 take precedence.
Similar Journals
Therapeutic Advances in Respiratory Disease
Empowering Progress in Respiratory Disease ManagementTherapeutic Advances in Respiratory Disease is a prestigious open-access journal published by SAGE Publications Ltd, based in the United Kingdom. Since its inception in 2007, it has established itself as a leading platform for the dissemination of cutting-edge research in the fields of pulmonary and respiratory medicine and pharmacology. With an impressive impact factor and ranking—showing it is in the Q1 quartile in both Pharmacology (medical) and Pulmonary and Respiratory Medicine as of 2023—the journal's commitment to high-quality research is evident. In 2023, it ranks #32 out of 155 in Pulmonary and Respiratory Medicine and #57 out of 272 in Medical Pharmacology, positioning it in the 79th percentile across these disciplines. Open access since 2018, the journal ensures that its valuable content is readily accessible to a global audience of researchers, healthcare professionals, and students, facilitating the rapid exchange of knowledge that is crucial in the ever-evolving landscape of respiratory health. The journal's objectives include advancing understanding of respiratory diseases through innovative research and promoting the development of therapeutic strategies that improve patient outcomes, making it an essential resource for those dedicated to respiratory medicine.
Advances in Respiratory Medicine
Transforming respiratory health through innovative research.Advances in Respiratory Medicine is a distinguished open-access journal published by MDPI, focusing on the latest research and developments in the field of pulmonary and respiratory medicine. Launched in 2015 and operating out of Switzerland, this journal aims to advance scientific discourse and knowledge by providing a platform for researchers, clinicians, and health professionals. With an impressive ISSN of 2451-4934 and an E-ISSN of 2543-6031, it has made its mark in the academic community, reflected by its impact factor and recognition in the Q3 category for Pulmonary and Respiratory Medicine as of 2023. The journal enjoys a ranking of #95 out of 155 in Scopus within its category, providing authors with visibility and the potential for impactful dissemination of their research. Open access since 2022, it ensures that findings are readily available to all, fostering collaboration and innovation across disciplines. With a commitment to quality and rigor, Advances in Respiratory Medicine invites contributions that push the boundaries of existing knowledge, making it an invaluable resource for anyone dedicated to enhancing respiratory health.
Minerva Respiratory Medicine
Transforming respiratory care with cutting-edge studies.Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.
Tuberkuloz ve Toraks-Tuberculosis and Thorax
Innovating the future of tuberculosis care.Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.
Annals of the American Thoracic Society
Connecting researchers and clinicians for a healthier tomorrow.Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.
EUROPEAN RESPIRATORY JOURNAL
Leading Insights for Pulmonary HealthThe EUROPEAN RESPIRATORY JOURNAL, published by EUROPEAN RESPIRATORY SOC JOURNALS LTD, is at the forefront of advancing knowledge in the fields of pulmonary and respiratory medicine. With its ISSN 0903-1936 and E-ISSN 1399-3003, this esteemed journal has established itself as a leading platform since its inception in 1988, currently converging towards 2024. Ranked in the Q1 category for both Medicine (miscellaneous) and Pulmonary and Respiratory Medicine in 2023, it stands as the 3rd of 155 journals in its field, reflecting an impressive 98th percentile Scopus ranking. The journal boasts a rigorous selection of peer-reviewed articles that encompass innovative research, clinical studies, and reviews, thereby enhancing the understanding and treatment of respiratory diseases. Although it does not currently offer an Open Access option, the journal remains crucial for researchers, clinicians, and healthcare professionals committed to improving respiratory health across Europe and beyond. Join a community dedicated to groundbreaking research and advancements in respiratory medicine.
Respiratory Investigation
Advancing knowledge in Pulmonary and Respiratory Medicine.Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.
RESPIRATORY MEDICINE
Exploring Breakthroughs in Lung HealthRespiratory Medicine is a leading journal in the field of pulmonary and respiratory medicine, dedicated to advancing knowledge and research from 1989 to 2024. Published by W B Saunders Co Ltd, this esteemed journal is recognized for its high impact, reflected in its Q1 quartile ranking in 2023 within the category of Pulmonary and Respiratory Medicine and its impressive Scopus ranking of 27 out of 155 journals, placing it in the 82nd percentile. With a focus on publishing groundbreaking research, comprehensive reviews, and innovative practices, Respiratory Medicine serves as an essential resource for health professionals, researchers, and students aiming to improve patient outcomes and understand complex respiratory conditions. While the journal is not Open Access, its contributions to the scientific community are invaluable, providing insights that drive both academic and clinical advancements in respiratory health.
RESPIROLOGY
Fostering Excellence in Pulmonary StudiesRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
INTERVIROLOGY
Your gateway to cutting-edge virology discoveries.INTERVIROLOGY is a leading academic journal dedicated to advancing the field of virology and infectious diseases, published by KARGER. With a commendable history since its inception in 1973, the journal is currently poised to explore innovative virological research through to 2024. INTERVIROLOGY is indexed with the ISSN 0300-5526 and E-ISSN 1423-0100, reflecting its commitment to maintaining high scholarly standards. The journal is categorized within the Q3 quartile for both Infectious Diseases and Virology as of 2023, demonstrating its relevance and contribution to the academic community. With Scopus rankings placing it as #130 in Infectious Diseases and #41 in Virology, INTERVIROLOGY serves as an essential resource for researchers, professionals, and students seeking cutting-edge insights and discoveries in virology. While it currently operates under a subscription model, its rigorous peer-review process ensures a high quality of published content, making it a cornerstone for those dedicated to understanding and combating viral diseases.